KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Biolife Solutions (BLFS) Return on Sales (2016 - 2025)

Biolife Solutions (BLFS) has disclosed Return on Sales for 16 consecutive years, with 0.4% as the latest value for Q4 2025.

  • On a quarterly basis, Return on Sales fell 39.0% to 0.4% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.08%, a 23.0% increase, with the full-year FY2025 number at 0.08%, up 23.0% from a year prior.
  • Return on Sales was 0.4% for Q4 2025 at Biolife Solutions, up from 0.13% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 2227.41% in Q4 2022 to a low of 1.8% in Q2 2022.
  • A 5-year average of 111.31% and a median of 0.06% in 2021 define the central range for Return on Sales.
  • Peak YoY movement for Return on Sales: soared 222783bps in 2022, then plummeted -222506bps in 2023.
  • Biolife Solutions' Return on Sales stood at 0.42% in 2021, then surged by 527845bps to 2227.41% in 2022, then crashed by -100bps to 2.35% in 2023, then tumbled by -66bps to 0.8% in 2024, then tumbled by -50bps to 0.4% in 2025.
  • Per Business Quant, the three most recent readings for BLFS's Return on Sales are 0.4% (Q4 2025), 0.13% (Q3 2025), and 0.13% (Q2 2025).